Rapid Risk Assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 16th update

The risk assessed in this update is as follows: based on current levels of vaccination coverage and the dominance of the Delta variant in the EU/EEA, what risk does SARS-CoV-2 pose to the general population and the vulnerable population in the coming months?